173 related articles for article (PubMed ID: 23300673)
1. ICU-associated Acinetobacter baumannii colonisation/infection in a high HIV-prevalence resource-poor setting.
Ntusi NB; Badri M; Khalfey H; Whitelaw A; Oliver S; Piercy J; Raine R; Joubert I; Dheda K
PLoS One; 2012; 7(12):e52452. PubMed ID: 23300673
[TBL] [Abstract][Full Text] [Related]
2. Nosocomial Acinetobacter baumannii infection in children in adult versus pediatric intensive care units.
Kim B; Kim K; Yoon JS
Pediatr Int; 2020 Apr; 62(4):451-458. PubMed ID: 31887243
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study.
Jang TN; Lee SH; Huang CH; Lee CL; Chen WY
J Hosp Infect; 2009 Oct; 73(2):143-50. PubMed ID: 19716203
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Acinetobacter baumannii infection in critically ill surgical patients.
Trottier V; Namias N; Pust DG; Nuwayhid Z; Manning R; Marttos AC; Dunham MB; Schulman CI; McKenney MG
Surg Infect (Larchmt); 2007 Aug; 8(4):437-43. PubMed ID: 17883360
[TBL] [Abstract][Full Text] [Related]
5. [Infections caused by Acinetobacter spp. in critically ill ICU patients].
Alvarez-Lerma F; Palomar M; Insausti J; Olaechea P; Cerdá E; Castillo F; Martínez-Pellús A;
Enferm Infecc Microbiol Clin; 2005 Nov; 23(9):533-9. PubMed ID: 16324565
[TBL] [Abstract][Full Text] [Related]
6. Mortality rates associated with multidrug-resistant Acinetobacter baumannii infection in surgical intensive care units.
Daniels TL; Deppen S; Arbogast PG; Griffin MR; Schaffner W; Talbot TR
Infect Control Hosp Epidemiol; 2008 Nov; 29(11):1080-3. PubMed ID: 18837670
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit.
Shi J; Sun T; Cui Y; Wang C; Wang F; Zhou Y; Miao H; Shan Y; Zhang Y
BMC Infect Dis; 2020 Aug; 20(1):597. PubMed ID: 32787942
[TBL] [Abstract][Full Text] [Related]
9. [Factors associated with mortality in Acinetobacter baumannii infected intensive care unit patients].
Karabay O; Yahyaoğlu M; Oğütlü A; Sandıkçı O; Tuna N; Ceylan S
Mikrobiyol Bul; 2012 Apr; 46(2):335-7. PubMed ID: 22639324
[TBL] [Abstract][Full Text] [Related]
10. Acinetobacter baumannii infections in a South African paediatric intensive care unit.
Reddy D; Morrow BM; Argent AC
J Trop Pediatr; 2015 Jun; 61(3):182-7. PubMed ID: 25833097
[TBL] [Abstract][Full Text] [Related]
11. [Acinetobacter baumannii - related mortality in intensive care units in Colombia].
Lemos EV; De la Hoz Restrepo F; Alvis N; Quevedo E; Cañon O; León Y
Rev Panam Salud Publica; 2011 Oct; 30(4):287-94. PubMed ID: 22124686
[TBL] [Abstract][Full Text] [Related]
12. Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit.
Young LS; Sabel AL; Price CS
Infect Control Hosp Epidemiol; 2007 Nov; 28(11):1247-54. PubMed ID: 17926275
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for nosocomial burn wound infection caused by multidrug resistant Acinetobacter baumannii.
Tekin R; Dal T; Bozkurt F; Deveci O; Palanc Y; Arslan E; Selçuk CT; Hoşoğlu S
J Burn Care Res; 2014; 35(1):e73-80. PubMed ID: 23799478
[TBL] [Abstract][Full Text] [Related]
14. A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.
Vasudevan A; Mukhopadhyay A; Li J; Yuen EG; Tambyah PA
BMC Infect Dis; 2014 Nov; 14():615. PubMed ID: 25420613
[TBL] [Abstract][Full Text] [Related]
15. Community-acquired bloodstream infections caused by Acinetobacter baumannii: A matched case-control study.
Chen CT; Wang YC; Kuo SC; Shih FH; Chen TL; How CK; Yang YS; Lee YT
J Microbiol Immunol Infect; 2018 Oct; 51(5):629-635. PubMed ID: 28701266
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for multidrug-resistant and extensively drug-resistant Acinetobacter baumannii infection of patients admitted in intensive care unit: a systematic review and meta-analysis.
Diao H; Lu G; Zhang Y; Wang Z; Liu X; Ma Q; Yu H; Li Y
J Hosp Infect; 2024 Jul; 149():77-87. PubMed ID: 38710306
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak.
Munoz-Price LS; Zembower T; Penugonda S; Schreckenberger P; Lavin MA; Welbel S; Vais D; Baig M; Mohapatra S; Quinn JP; Weinstein RA
Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1057-62. PubMed ID: 20715975
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.
Baran G; Erbay A; Bodur H; Ongürü P; Akinci E; Balaban N; Cevik MA
Int J Infect Dis; 2008 Jan; 12(1):16-21. PubMed ID: 17513154
[TBL] [Abstract][Full Text] [Related]
19. The incidence and prevalence of hospital-acquired (carbapenem-resistant)
Ayobami O; Willrich N; Harder T; Okeke IN; Eckmanns T; Markwart R
Emerg Microbes Infect; 2019; 8(1):1747-1759. PubMed ID: 31805829
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of drug resistance of Acinetobacter baumannii and its related factors in ICU].
Ma MY; Xu J; Yu N; Huang GM
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Nov; 25(11):686-9. PubMed ID: 24225215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]